JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Tel: +1-832-696-8203
Email: [email protected]
Worldwide Distributors
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
Cell lines
Rat astrocytes
Reaction Conditions
0.1 ~ 1 μM ouabain
Applications
In cultured rat astrocytes, 0.1 ~ 1 μM of ouabain inhibited the Na+ pump and increased stored Ca2+. As an inhibitor of the Na+ pump, ouabain could be used to explore the distribution and function of the isoforms of the Na+ pump catalytic (α) subunit due to its different affinity for each isoform.
Animal models
Male Wistar rats with heart failure due to myocardial infarction (MI)
Dosage form
14.4 mg/kg/day
Injected subcutaneously (s.c.) for 2 weeks; either continuously (osmotic minipumps) or intermittently (once daily)
Ouabain (14.4 mg/kg/day; s.c.; intermittent) further increased total peripheral resistance (TPR) in rats with heart failure due to MI, while continuous ouabain treatment normalized TPR in MI rats. Ouabain (14.4 mg/kg.d; s.c.; continuous) significantly improved basal and maximal CO.
Note
The technical data provided above is for reference only.
References:
1. Juhaszova M, Blaustein MP. Na+ pump low and high ouabain affinity alpha subunit isoforms are differently distributed in cells. Proceedings of the National Academy of Sciences of the United States of America, 1997, 94(5): 1800-1805.
2. Nelissen-Vrancken HJ, Wang JF, Struijker Boudier HA, et al. Ouabain improves cardiac function in vivo in rats with heart failure after chronic but not acute treatment. Naunyn-Schmiedeberg's Archives of Pharmacology, 1997, 356(2): 203-209.